Per molecular classification, TNBC denotes ER-/PR-/HER2-breast cancer exhibiting peak malignancy potential and minimal survival expectancy among mammary carcinomas [[2], [3], [4], [5]]. This evidence concerns the gene ERBB2 and breast carcinoma.